Deep Venous Thrombosis Dvt
Mostrando 1-12 de 13 artigos, teses e dissertações.
-
1. Pulmonary hypertension could be a risk for deep vein thrombosis in lower extremities after joint replacement surgery
RESUMO OBJETIVO A hipertensão pulmonar (HP) indica elevação progressiva da resistência vascular pulmonar, levando ao excesso de enchimento, elevação da pressão venosa, congestão em vários órgãos e edema no sistema venoso. Este estudo teve como objetivo investigar se a HP é um fator de risco para trombose venosa profunda (TVP) das extremidades i
Rev. Assoc. Med. Bras.. Publicado em: 05/08/2019
-
2. Análise do grau de recanalização da trombose venosa profunda: estudo comparativo de pacientes tratados com varfarina versus rivaroxabana
Resumo Contexto A trombose venosa profunda (TVP) afeta anualmente cerca de dez milhões de pessoas no mundo e tem como principais complicações a embolia pulmonar e a síndrome pós-trombótica. O tratamento padrão é a anticoagulação, que pode ser realizada com heparinas, antagonistas da vitamina K, fondaparinux ou, mais recentemente, com anticoagulant
J. vasc. bras.. Publicado em: 27/06/2019
-
3. Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan
Introduction Although venous thromboembolism (VTE) is seen with morbidity and mortality in various surgical specialties, scarce data are available in the head and neck surgery domain.
Objective We aim to determine the incidence of VTE in patients receiving surgery for head and neck cancer.
< Int. Arch. Otorhinolaryngol.. Publicado em: 2015
-
4. Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors
Deep venous thrombosis (DVT) is a common surgical complication in cancer patients and evidence that inflammation plays a role in the occurrence of DVT is increasing. We studied a population of cancer patients with abdominal malignancies with the aim of investigating whether the levels of circulating inflammatory cytokines were associated with postoperative D
Braz J Med Biol Res. Publicado em: 22/08/2014
-
5. Long-term clinical and ultrasonographic evaluation of thrombophilic patients with deep venous thrombosis
OBJECTIVE: The purpose of this study was to evaluate the long term clinical and ultrasonographic outcomes of thrombophilic patients with deep venous thrombosis (DVT). METHOD: Cohort study, retrospective case-control with cross-sectional analysis. Thirty-nine thrombophilic patients and 25 non-thrombophilic patients were assessed 76.3 ± 45.8 months afte
J. vasc. bras.. Publicado em: 2014-03
-
6. Avaliação das células endoteliais circulantes na trombose venosa profunda : pacientes e modelo animal / Evaluation of the circulating endothelial cell in deep venous thrombosis : patients and animal model
Endothelial cells participate in hemostasia and have pro and anti thrombotic effects which can be stimulated by an endothelial lesion. The presence of endothelial cells in circulation can be considered a novel marker of vascular integrity, as described in several pathologies, such as: cardiovascular disease, infectious disease, immune diseases, transplants
Publicado em: 2010
-
7. Preparação e caracterização de nanoparticulas com heparina e sua avaliação em modelo animal de trombose venosa / Preparation and characterization of heparin-loaded nanoparticles and its evaluation in animal model of venous thrombosis
Heparin is an anticoagulant widely used in the treatment and prophylaxis of deep vein thrombosis (DVT). Some limitations of its use is the cost and route of administration, intravenous or subcutaneous, sometimes in repeated doses in 24 hours. Thus, the development of a product that can be administered subcutaneously in a smaller number of applications or ora
Publicado em: 2010
-
8. Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population
Most cases of a predisposition to venous thrombosis are caused by resistance to activated protein C, associated in 95% of cases with the Factor V Leiden allele (FVL or R506Q). Several recent studies report a further increased risk of thrombosis by an association between the AB alleles of the ABO blood group and Factor V Leiden. The present study investigated
Genetics and Molecular Biology. Publicado em: 2009
-
9. AlteraÃÃo bioquÃmica em fator de coagulaÃÃo como causa de trombose venosa profunda â relato de caso clÃnico
Deep venous thrombosis (DVT) in the pediatric population (0-18 year old) has been reported as lower than in adults. In almost half of the children, three or four risk factors for thrombosis are present simultaneously. Even in children with thromboembolic disturbance, thrombosis did not occur spontaneously; the hemostatic defect became apparent because thromb
Publicado em: 2006
-
10. Associação dos polimorfismos nos genes dos receptores alfa e beta do estrogeno em pacientes com trombose venosa profunda / Association of polymorphisms in (alpha) and (beta) estrogen receptor genes in patients with deep venous thrombosis
Estrogen acts in haemostasis promoting pro and antithrombotic effects. Its action occurs through linking the specific nuclear receptors called alfa and beta estrogen receptor (ER). Polymorphisms in the genes that codify the ER a and ~could modulate estrogen response, as well as gene transcription and expression. There are acquired risk factors for deep venou
Publicado em: 2006
-
11. An instrument for measuring health-related quality of life in patients with Deep Venous Thrombosis (DVT): development and validation of Deep Venous Thrombosis Quality of Life (DVTQOL) questionnaire
BioMed Central.
-
12. Automated Computer Interviews to Elicit Utilities: Potential Applications in the Treatment of Deep Venous Thrombosis
Objective: To assess the practicality of an automated computer interview as a method to assess preferences for use in decision making. To assess preferences for outcomes of deep vein thrombosis (DVT) and its treatment.
American Medical Informatics Association.